This limiting mechanism by oSCRIB region seemed to restrain the overexpression of SCRIB as a cancer-promoting POTSF not only in normal cells but also in cancer cells; however, our clinical proteomic data reanalysis indicated that it was dysregulated in cancer cells for SCRIB overexpression, resulting in their survival and proliferation. Here, SCRIB is linked to cancer.